JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB98624

Goat Anti-Human IgG Fc (HRP) preadsorbed

5

(2 Reviews)

|

(40 Publications)

Goat Anti-Human IgG Fc (HRP) is a preadsorbed secondary antibody for chemiluminescent detection. Ideal for Western blot. Suitable for Western blot, IHC, ELISA and ICC.

- Preadsorbed to prevent cross-reactivity and reduce background staining
- Cited in over 30 publications

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

12 Images
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Supplier Data

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

This data was developed using ab289981, the same antibody clone in a different buffer formulation.

Blocking and diluting buffer and concnetration are 5% NFDM/TBST.

ab289981 detects a ranged of myc tagged proteins in WB.

All lanes:

Western blot - Anti-Myc tag antibody [Hyper-myc] (<a href='/en-us/products/primary-antibodies/myc-tag-antibody-hyper-myc-ab289981'>ab289981</a>) at 1/5000 dilution

Lane 1:

HEK-293T (human embryonic kidney) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 1 µg

Lane 2:

HEK-293T transfected with cas9 ( S. Aureas) expression vector containing a myc-His-tag®, whole cell lysate at 1 µg

Lane 3:

HEK-293T transfected with human SNCA140 expression vector containing a myc-His-tag®, whole cell lysate at 1 µg

Lane 4:

HEK-293T transfected with human IDS expression vector containing a myc-His-tag®, whole cell lysate at 1 µg

Lane 5:

HEK-293T transfected with human NF2 S518A expression vector containing a myc-His-tag®, whole cell lysate at 1 µg

Lane 6:

HEK-293T transfected with human Alpha-synuclein expression vector containing a myc-His-tag®, whole cell lysate at 1 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Predicted band size: 49 kDa

false

Exposure time: 1s

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Lab

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

All lanes:

Western blot - Anti-HMGB1 antibody [EPR21207] (<a href='/en-us/products/primary-antibodies/hmgb1-antibody-epr21207-ab213256'>ab213256</a>) at 1/100 dilution

Lane 1:

HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 3:

SK-BR-3 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 4:

A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 5:

parental HAP1(HOWT01) (human chronic myelogenous leukemia near-haploid cell ) whole cell lysate at 20 µg

Lane 6:

HMGB1 knockout HAP1 whole cell lysate at 20 µg

Lane 7:

MEF (mouse embryo fibroblast) whole cell lysate at 20 µg

Lane 8:

NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg

Lane 9:

Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

false

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Supplier Data

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The expression profile observed is consistent with what has been described in the literature (PMID : 27043630).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

In Western blot, Anti-Rho A + B + C antibody [EPR18299] staining at 1/1000 dilution.

All lanes:

Western blot - Anti-RhoA + RhoB (ADP-ribosylated) antibody [VIF140-A1] (<a href='/en-us/products/primary-antibodies/rhoa-rhob-adp-ribosylated-antibody-vif140-a1-ab324028'>ab324028</a>) at 1/1000 dilution

Lane 1:

Untreated HT-22 (mouse hippocampal neuronal cell) whole cell lysate at 20 µg

Lane 2:

HT-22 treated with 500nM C3 for 6 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Observed band size: 22 kDa,36 kDa

false

Exposure time: 26s

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Supplier Data

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Blocking buffer and concentration : 5% NFDM/TBST  Diluting buffer and concentration : 5% NFDM/TBST Exposure Time : Lane 1 : 3 seconds, Lane 2-3 : 20 seconds. Negative control : Skeletal muscle. The identity of the bands between 27 kDa and 150 kDa are unknown. ab181602 was used as a loading control.

All lanes:

Western blot - Anti-TAGLN/Transgelin antibody [EPR21206] (<a href='/en-us/products/primary-antibodies/tagln-transgelin-antibody-epr21206-ab213273'>ab213273</a>) at 1/500 dilution

Lane 1:

Rat bladder tissue lysate at 20 µg

Lane 2:

Rat colon tissue lysate at 20 µg

Lane 3:

Rat skeletal muscle tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Lab

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Blocking and diluting buffer was 5% NFDM/TBST

All lanes:

Western blot - Anti-PLBD2 antibody [IGX4128H] (<a href='/en-us/products/primary-antibodies/plbd2-antibody-igx4128h-ab213295'>ab213295</a>) at 1/1000 dilution

Lane 1:

Mouse brain tissue lysate at 20 µg

Lane 2:

Mouse heart tissue lysate at 20 µg

Lane 3:

Human cerebellum tissue lysate at 20 µg

Lane 4:

Rat brain tissue lysate at 20 µg

Lane 5:

Rat heart tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

false

Exposure time: 4s

Indirect ELISA - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • I-ELISA

Lab

Indirect ELISA - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Indirect ELISA showing primary antibody ab323000 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105), Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) and Recombinant human coronavirus SARS spike glycoprotein (Tagged, ab270844) at 1000 ng/ml. Binding of ab323000 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) was used at 1 : 5000.

Indirect ELISA - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • I-ELISA

Lab

Indirect ELISA - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Indirect ELISA showing primary antibody ab322272 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105) and Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) at 1000 ng/ml. Binding of ab322272 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) was used at 1 : 5000.

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Lab

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

False colour image of Western blot : Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [8B12-C2] - Human IgG1 (Chimeric) (ab322272) staining at 1/500 dilution, shown in black; Mouse Monoclonal 6X His tag® (ab18184) loading control staining at 1/200 dilution, shown in red. In Western blot, ab322272 was shown to bind specifically to SARS-CoV and SARS-CoV-2 Spike Glycoproteins. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1 : 10000 and Goat anti-Mouse IgG H&L 680RD at 1 : 20000.

All lanes:

Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 [8B12-C2] – Human IgG1 (Chimeric) (<a href='/en-us/products/primary-antibodies/sars-cov-2-spike-glycoprotein-s1-8b12-c2-human-igg1-chimeric-ab322272'>ab322272</a>) at 1/500 dilution

Lane 1:

Western blot - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s1-active-ab273068'>ab273068</a>) at 0.2 µg

Lane 2:

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His Recombinant Protein at 0.2 µg

Lane 3:

SARS-CoV Spike S1+S2 ECD-His Recombinant Protein at 0.2 µg

Secondary

Lanes 1 - 3:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Lanes 1 - 3:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 120-160 kDa

false

Exposure time: 5s

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Lab

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Lane 1 : Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active, His tagged) (ab273068) at 0.2 ug

Lane 2 : Recombinant SARS-COV-2 NSP2 protein (His tagged) at 0.2 ug

Performed under reducing conditions.

Observed band size : 135 kDa.

False colour image of Western blot : Rabbit monoclonal [EPR24852-116] to SARS-CoV-2 Spike Glycoprotein S1 - Human IgG1 (Chimeric), ab323000 staining at 1/500 dilution, shown in black; Mouse Monoclonal 6X His tag® (ab18184) loading control staining at 1/1000 dilution, shown in red. In Western blot, ab323000 was shown to bind specifically to SARS-CoV-2 spike glycoprotein S1. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1 : 10000 and Goat anti-Mouse IgG H&L 680RD at 1 : 20000.

Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T).

Exposure time : 30 Sec.

All lanes:

Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Human IgG1 (Chimeric) (<a href='/en-us/products/primary-antibodies/sars-cov-2-spike-glycoprotein-s1-antibody-epr24852-116-human-igg1-chimeric-ab323000'>ab323000</a>) at 1/500 dilution

Lane 1:

Western blot - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s1-active-ab273068'>ab273068</a>) at 0.2 µg

Lane 2:

Recombinant SARS-COV-2 NSP2 protein (His tagged) at 0.2 µg

Secondary

Lanes 1 - 2:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Lanes 1 - 2:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 135 kDa

false

Exposure time: 30s

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Supplier Data

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

The expression profile observed is consistent with what has been described in the literature (PMID : 27043630).

In Western blot, Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade (ab176842) staining at 1/200000 dilution.

In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.

In Western blot, Anti-Rho A + B + C antibody [EPR18299] staining at 1/1000 dilution.

All lanes:

Western blot - Anti-RhoA + RhoB (ADP-ribosylated) antibody [VIF140-A1] (<a href='/en-us/products/primary-antibodies/rhoa-rhob-adp-ribosylated-antibody-vif140-a1-ab324028'>ab324028</a>) at 1/1000 dilution

Lane 1:

293T (human embryonic kidney epithelial cell) transfected with an empty vector containing a myc-his-tag whole cell lysate at 20 µg

Lane 2:

293T transfected with an empty vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg

Lane 3:

293T transfected with an human RhoA expression vector containing a myc-his-tag whole cell lysate at 20 µg

Lane 4:

293T transfected with an human RhoA expression vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg

Lane 5:

293T transfected with an human RhoB expression vector containing a myc-his-tag whole cell lysate at 20 µg

Lane 6:

293T transfected with an human RhoB expression vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg

Lane 7:

293T transfected with an human RhoC expression vector containing a myc-his-tag whole cell lysate at 20 µg

Lane 8:

293T transfected with an human RhoC expression vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Observed band size: 22 kDa,17 kDa

false

Exposure time: 1s

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • WB

Supplier Data

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

False colour image of Western blot : Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] - BSA and Azide free - Human IgG1 (Chimeric) (ab324889) staining at 1/1000 dilution, shown in black.

In Western blot, ab324889 was shown to bind specifically to SARS-CoV-2 Spike Glycoprotein S2. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1h at room temperature, washed again four times then imaged.

Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T)

All lanes:

Western blot - Anti-SARS-CoV-2 S Glycoprotein S2 antibody [EPR25038-122] - Human IgG1 (Chimeric) - BSA & Azide free (<a href='/en-us/products/primary-antibodies/sars-cov-2-spike-glycoprotein-s2-antibody-epr25038-122-human-igg1-chimeric-bsa-and-azide-free-ab324889'>ab324889</a>) at 1/1000 dilution

Lane 1:

Western blot - Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s2-fc-chimera-ab272106'>ab272106</a>) at 0.2 µg

Lane 2:

Western blot - Recombinant Human coronavirus SARS-CoV-2 nucleocapsid protein (His tag) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-nucleocapsid-protein-his-tag-ab273530'>ab273530</a>) at 0.2 µg

Secondary

All lanes:

Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

Observed band size: 135 kDa

false

Exposure time: 10s

Dot Blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
  • Dot

Supplier Data

Dot Blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)

Dot blot analysis of bat SARS-like coronavirus RsSHC014 Spike glycoprotein using ab317329 at 1 : 1000 followed by a Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1 : 10,000 dilution.

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Dot Blot - Anti-bat SARS-like coronavirus RsSHC014 Spike glycoprotein antibody [abd166] (<a href='/en-us/products/primary-antibodies/bat-sars-like-coronavirus-rsshc014-spike-glycoprotein-antibody-abd166-ab317329'>ab317329</a>) at 1/1000 dilution

Lane 1:

293T cells transfected with an empty vector containing a myc-his tag whole cell lysate

Lane 2:

293T cells transfected with a Bat Spike glycoprotein expression vector containing a myc-his-tag whole cell lysate

Lane 3:

His-tagged bat SARS-like coronavirus RsSHC01 recombinant fragment protein

Secondary

All lanes:

Dot Blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution

false

Exposure time: 180s

Key facts

Host species

Goat

Target species

Human

Target isotype

IgG

Target specificity

Fc region

Minimal cross-reactivity

Mouse, Rat, Sheep, Rabbit, Goat, Horse, Chicken, Cow,

Pre-adsorbed

Yes

Conjugation

HRP

Excitation/Emission
Applications

IHC-P, WB, ELISA, ICC

applications

Clonality

Polyclonal

Isotype

IgG

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/2000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/100000", "notes":"<p>(Primary).</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/2000 - 1/25000", "notes":"<p>(Colorimetric: 1/2000 - 1/20000; Chemiluminescent: 1/5000 - 1/25000).</p>" } } }

Product details

This antibody reacts with the Fc region of Human IgG

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase.
Storage buffer
pH: 6.8 - 7.4 Constituents: PBS, 0.2% BSA, 0.00063% 5-chloro-2-methyl-4-isothiazolin-3-one, 0.00063% 2-methyl-4-isothiazolin-3-one
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Additional targets

IGHG2,IGHG3,IGHG4

Publications (40)

Recent publications for all applications. Explore the full list and refine your search

Arthritis research & therapy 27:133 PubMed40604930

2025

Anti-interferon-α antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Sun,Hongxia Yang,Yingfang Zhang,Shiyu Wu,Xinxin Zhang,Wei Jiang,Qinglin Peng,Guochun Wang,Xin Lu

Frontiers in immunology 15:1490044 PubMed39640268

2024

mRNA-based platform for preventing and treating by targeted staphylococcal enterotoxin B.

Applications

Unspecified application

Species

Unspecified reactive species

Fumei Luo,Chuanfei Xu,Chengwen Zhang,Aomo Tan,Dongshui Lu,Ping Luo,Ping Cheng,Weijun Zhang,Lijuan Bai,Cuiyun Yu,Si Sun,Hao Zeng,Quanming Zou

Journal of neuroinflammation 21:317 PubMed39627772

2024

Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns.

Applications

Unspecified application

Species

Unspecified reactive species

Luisa Knecht,Katrine Dalsbøl,Anja Hviid Simonsen,Falk Pilchner,Jean Alexander Ross,Kristian Winge,Lisette Salvesen,Sara Bech,Anne-Mette Hejl,Annemette Løkkegaard,Steen G Hasselbalch,Richard Dodel,Susana Aznar,Gunhild Waldemar,Tomasz Brudek,Jonas Folke

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 39:153-165 PubMed39614966

2024

Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Malte Lenders,Elise Raphaela Menke,Michael Rudnicki,Markus Cybulla,Eva Brand

Journal of bacteriology 206:e0031224 PubMed39530727

2024

Quorum sensing regulation of Psl polysaccharide production by .

Applications

Unspecified application

Species

Unspecified reactive species

Jeffrey N Carey,Sabrina Lamont,Daniel J Wozniak,Ajai A Dandekar,Matthew R Parsek

Antiviral research 227:105914 PubMed38759930

2024

Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Francisco J Mancebo,Marcos Nuévalos,Jaanam Lalchandani,Antonio J Martín Galiano,Mario Fernández-Ruiz,José María Aguado,Estéfani García-Ríos,Pilar Pérez-Romero

Communications biology 7:294 PubMed38461214

2024

Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice.

Applications

Unspecified application

Species

Unspecified reactive species

Fan Yang,Alireza Labani-Motlagh,Jose Alejandro Bohorquez,Josimar Dornelas Moreira,Danish Ansari,Sahil Patel,Fabrizio Spagnolo,Jon Florence,Abhinav Vankayalapati,Tsuyoshi Sakai,Osamu Sato,Mitsuo Ikebe,Ramakrishna Vankayalapati,John J Dennehy,Buka Samten,Guohua Yi

eLife 12: PubMed38127423

2023

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment.

Applications

Unspecified application

Species

Unspecified reactive species

Musleh M Muthana,Xuexiang Du,Mingyue Liu,Xu Wang,Wei Wu,Chunxia Ai,Lishan Su,Pan Zheng,Yang Liu

Nature communications 14:5948 PubMed37741831

2023

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.

Applications

Unspecified application

Species

Unspecified reactive species

Ashley D Otter,Scott Jones,Bethany Hicks,Daniel Bailey,Helen Callaby,Catherine Houlihan,Tommy Rampling,Nicola Claire Gordon,Hannah Selman,Panayampalli S Satheshkumar,Michael Townsend,Ravi Mehta,Marcus Pond,Rachael Jones,Deborah Wright,Clarissa Oeser,Simon Tonge,Ezra Linley,Georgia Hemingway,Tom Coleman,Sebastian Millward,Aaron Lloyd,Inger Damon,Tim Brooks,Richard Vipond,Cathy Rowe,Bassam Hallis

mAbs 15:2232087 PubMed37408314

2023

Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework.

Applications

Unspecified application

Species

Unspecified reactive species

Romain Ollier,Aline Fuchs,Florence Gauye,Katarzyna Piorkowska,Sébastien Menant,Monisha Ratnam,Paolo Montanari,Florence Guilhot,Didier Phillipe,Mickael Audrain,Anne-Laure Egesipe,Damien Névoltris,Tamara Seredenina,Andrea Pfeifer,Marie Kosco-Vilbois,Tariq Afroz
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com